Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Neumología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Activo, no recluta
Fase 2
ClinicalTrials.gov
A Phase 2, Randomized, Open-label, Platform Study Utilizing a Master Protocol to Evaluate Novel Immunotherapy Combinations in Participants With Previously Untreated, Locally Advanced/Metastatic, Programmed Death Ligand 1-Selected Non-Small-Cell Lung Cancer
INTERVENTIONAL
Inicio: 14 de oct de 2022
ID: NCT05565378
Terminado
Fase 3
ClinicalTrials.gov
GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Resectable MAGE-A3 Positive Non-Small Cell Lung Cancer
INTERVENTIONAL
Inicio: 4 de oct de 2007
ID: NCT00480025
Completado
Fase 3
ClinicalTrials.gov
A Phase III, Open-Label, Randomized Study of Atezolizumab and Tiragolumab Compared With Durvalumab in Patients With Locally Advanced, Unresectable Stage III Non-Small Cell Lung Cancer Who Have Not Progressed After Concurrent Platinum-Based Chemoradiation
INTERVENTIONAL
Inicio: 24 de ago de 2020
ID: NCT04513925
Desconocido
ClinicalTrials.gov
Hospitalary Chronic Obstructive Pulmonary Disease Registry
OBSERVATIONAL
Inicio: 1 de jul de 2016
ID: NCT02659189
Completado
Fase 3
ClinicalTrials.gov
A Randomised, Double-blind, Active-controlled Parallel Group Study to Evaluate the Effect of 52 Weeks of Once Daily Treatment of Orally Inhaled Tiotropium + Olodaterol Fixed Dose Combination Compared With Tiotropium on Chronic Obstructive Pulmonary Disease (COPD) Exacerbation in Patients With Severe to Very Severe COPD. [DYNAGITO]
INTERVENTIONAL
Inicio: 13 de ene de 2015
ID: NCT02296138
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized Study of Nivolumab Plus Ipilimumab in Combination With Chemotherapy vs Chemotherapy Alone as First Line Therapy in Stage IV Non-Small Cell Lung Cancer
INTERVENTIONAL
Inicio: 24 de ago de 2017
ID: NCT03215706
Reclutando
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Open-label, Multicenter Clinical Study to Evaluate the Safety and Efficacy of MK-1084 in Combination With Subcutaneous Pembrolizumab and Berahyaluronidase Alfa (MK-3475A) Versus MK-3475A in Combination With Pemetrexed/Platinum (Carboplatin or Cisplatin) Chemotherapy as First-line Treatment of Participants With KRAS G12C-Mutant, Advanced or Metastatic Nonsquamous NSCLC (KANDLELIT-007)
INTERVENTIONAL
Inicio: 8 de oct de 2025
ID: NCT07190248
Completado
Fase 4
ClinicalTrials.gov
Randomized Controlled Trial of High Dose of Vitamin D as Compared With Placebo to Prevent Complications Among COVID-19 Patients
INTERVENTIONAL
Inicio: 11 de ago de 2020
ID: NCT04411446
Terminado
ClinicalTrials.gov
Noninvasive Mechanical Ventilation in Severe Community-Acquired Pneumonia and Acute Hypoxemic Respiratory Failure. A Prospective, Randomized and Controlled Study
INTERVENTIONAL
ID: NCT00523497
Completado
Fase 3
ClinicalTrials.gov
Phase 3 Randomized Study of TLK286 (Telcyta) Versus Gefitinib (Iressa) as Third-Line Therapy in Locally Advanced or Metastatic Non-Small Cell Lung Cancer
INTERVENTIONAL
ID: NCT00080340
Completado
ClinicalTrials.gov
An International Observational Study to Characterize Adults With Influenza or Other Targeted Respiratory Viruses
OBSERVATIONAL
Inicio: 1 de ago de 2009
ID: NCT01056354
Reclutando
Fase 3
ClinicalTrials.gov
Prospective, Randomised, DBPC, Multicenter Clinical Trial to Evaluate Efficacy and Safety of Sublingual Immunotherapy in Patients With Rhinitis/Rhinoconjunctivitis With or Without Mild to Moderate Asthma, Allergic to Dpt and/or Df
INTERVENTIONAL
Inicio: 2 de abr de 2025
ID: NCT07348302
Reclutando
Fase 2
ClinicalTrials.gov
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel-group, Dose-Ranging Study to Investigate the Efficacy and Safety of PF-07275315 in Adult Participants With Inadequately Controlled Moderate-to-Severe Asthma
INTERVENTIONAL
Inicio: 20 de may de 2025
ID: NCT06977581
Completado
ClinicalTrials.gov
Cohort of COVID19 Patients Admitted to Pasteur Clinic 2020-2021
OBSERVATIONAL
Inicio: 20 de mar de 2020
ID: NCT05087394
Activo, no recluta
ClinicalTrials.gov
PROSpect: Prone and Oscillation Pediatric Clinical Trial
INTERVENTIONAL
Inicio: 1 de may de 2019
ID: NCT03896763
Completado
Fase 2
ClinicalTrials.gov
A Phase 2, Randomized, Double-Blind, Multicenter, Placebo-Controlled Study to Evaluate the Safety and Tolerability of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease
INTERVENTIONAL
Inicio: 22 de dic de 2022
ID: NCT05176951
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Randomized, Open-label, Phase 3 Study of Tarlatamab Compared With Standard of Care in Subjects With Relapsed Small Cell Lung Cancer After Platinum-based First-line Chemotherapy
INTERVENTIONAL
Inicio: 31 de may de 2023
ID: NCT05740566
Reclutando
Fase 3
ClinicalTrials.gov
A Phase 3, Multicenter, Randomized, Open-label Trial of Trastuzumab Deruxtecan in Combination With Pembrolizumab Versus Platinum-based Chemotherapy in Combination With Pembrolizumab, as First-line Therapy in Participants With Locally Advanced Unresectable or Metastatic HER2 Overexpressing and PD-L1 TPS <50% Non-squamous Non-small Cell Lung Cancer (DESTINY-Lung06)
INTERVENTIONAL
Inicio: 24 de oct de 2025
ID: NCT06899126
Completado
Fase 3
ClinicalTrials.gov
Phase 3, Randomized, Placebo-Controlled, Efficacy and Safety Study of VERU-111 for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Patients at High Risk for Acute Respiratory Distress Syndrome (ARDS).
INTERVENTIONAL
Inicio: 18 de may de 2021
ID: NCT04842747
Completado
Fase 3
ClinicalTrials.gov
A Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 1
INTERVENTIONAL
Inicio: 1 de oct de 2013
ID: NCT01957163
Anterior
1
...
15
16
17
...
434
Siguiente
Filtros